Abstract
We carried out a retrospective immunohistochemical study of Ki-67, PCNA, Bcl-2, BAX, BclX, and VEGF expression in tumors of two groups of breast cancer patients with favorable and unfavorable course of the disease. Considerably enhanced VEGF expression was detected in tumors of patients with early relapses of breast cancer. High VEGF expression was paralleled by high level of Ki-67 and PCNA expression in tumors. It can be hypothesized that expression of VEGF, Ki-67, and PCNA in primary tumor can be used for predicting the course of breast cancer or detecting the patients at a high risk of early relapses.
Similar content being viewed by others
REFERENCES
E. S. Gershtein and N. E. Kushlinskii, Prakt. Onkol., 3, No. 1, 38–44 (2002).
N. E. Kushlinskii and E. S. Gershtein, Byull. Eksp. Biol. Med., 133, No. 6, 604–612 (2002).
N. N. Trapeznikov and E. M. Aksel', Malignant Tumors Morbidity and Mortality in the Population of the CIS Countries [in Russian], Moscow (2001).
J. Adams, P. J. Carder, S. Downey, et al., Cancer Res., 60, No. 11, 2898–2905 (2000).
K. Anan, T. Morisaki, M. Katano, et al., Eur. J. Surg. Oncol., 24, No. 1, 28–33 (1998).
S. W. Beenken and K. I. Bland, Minerva Chir., 57, No. 4, 437–448 (2002).
A. Biroccio, A. Candiloro, M. Mottolese, et al., FASEB J., 14, No. 5, 652–660 (2000).
N. Ferrara, Breast Cancer Res. Treat., 36, No. 2, 127–137 (1995).
J. Folkman, J. Natl. Cancer Inst., 82, 4–6 (1990).
G. Gasparini, Crit. Rev. Oncol. Hematol., 37, No. 2, 97–114 (2001).
T. Kato, S. Kameoka, T. Kimura, et al., Anticancer Res., 22, No. 2B, 1097–1103 (2002).
A. Kranz, T. Mattfeldt, and J. Waltenberger, Int. J. Cancer, 84, No. 3, 293–298 (1999).
M. Toi, S. Hoshina, T. Takayanagi, and T. Tominaga, Jpn. J. Cancer Res., 85, 1045–1049 (1994).
H. Trihia, S. Murray, K. Price, et al., Cancer, 97, No. 5, 1321–1331 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kushlinskii, N.E., Orinovskii, M.B., Gurevich, L.E. et al. Expression of Biomolecular Markers (Ki-67, PCNA, Bcl-2, BAX, BclX, VEGF) in Breast Tumors. Bulletin of Experimental Biology and Medicine 137, 182–185 (2004). https://doi.org/10.1023/B:BEBM.0000028135.91289.e9
Issue Date:
DOI: https://doi.org/10.1023/B:BEBM.0000028135.91289.e9